Compare BMRN & IDCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BMRN | IDCC |
|---|---|---|
| Founded | 1996 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Multi-Sector Companies |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4B | 8.9B |
| IPO Year | 1999 | 2007 |
| Metric | BMRN | IDCC |
|---|---|---|
| Price | $49.61 | $262.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 2 |
| Target Price | $88.22 | ★ $412.50 |
| AVG Volume (30 Days) | ★ 1.7M | 325.0K |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.79% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.54 | ★ 2.14 |
| Revenue | ★ $1,313,646,000.00 | $307,404,000.00 |
| Revenue This Year | $15.02 | N/A |
| Revenue Next Year | $12.23 | $3.38 |
| P/E Ratio | ★ $95.96 | $122.05 |
| Revenue Growth | ★ 17.62 | N/A |
| 52 Week Low | $50.76 | $205.78 |
| 52 Week High | $66.28 | $412.60 |
| Indicator | BMRN | IDCC |
|---|---|---|
| Relative Strength Index (RSI) | 31.83 | 28.38 |
| Support Level | N/A | $260.94 |
| Resistance Level | $56.91 | $276.88 |
| Average True Range (ATR) | 1.85 | 15.82 |
| MACD | -0.25 | -3.86 |
| Stochastic Oscillator | 4.96 | 5.43 |
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
InterDigital Inc is a research and development company focused on wireless, video, Artificial Intelligence, and related technologies. It designs and develops technologies that enable connected, immersive experiences in a broad range of communications and entertainment products and services. The majority of revenue is generated from fixed-fee patent license agreements, with a smaller portion coming from variable royalty agreements. Geographically it operates in the United States, China, South Korea, Japan, Taiwan, and Europe, out of which the majority is from China.